Interventional Management of Chronic Visceral Pain Syndromes

1. Epidemiology of Visceral Pain Syndromes

2. Neuroanatomy and Mechanisms of Visceral Pain

Pelvic Pain Syndromes

3. Female Pelvic Pain

4. Malignant Pelvic Pain

5. Chronic Prostatitis

6. Coccydynia

7. Pudendal Neuralgia

8. Post-Surgical Pelvic Pain

9. Functional Anorectal Pain

Malignant Gastrointestinal Pain

10. Pancreatic Cancer

11. Liver cancer

12. Gastric cancer

13. Colorectal cancer

Non-Malignant Gastrointestinal Pain

14. Chronic pancreatitis

15. Chronic post-surgical pain (CPSP)

16. Chronic abdominal wall pain

17. Mesenteric ischemia

18. Inflammatory Bowel Disease

19. Irritable bowel syndrome

Chest Pain

20. Postherpetic Neuralgia

21. Atypical Chest Wall Pain

22. Esophagitis

23. Gastroesophageal Reflex Disease

Offering timely coverage of this complex field  Interventional Management of Chronic Visceral Pain Syndromes is a practical evidence-based guide for the mechanisms presentation diagnosis and treatments of chronic non-malignant and malignant abdominal pain syndromes. Experienced clinicians and academic leaders in pain medicine comprehensively discuss best-practice guidelines using the newest interventional techniques including dorsal root ganglion stimulation high frequency spinal cord stimulation and low-dose intrathecal infusion pumps. Coverage includes malignant and non-malignant gastrointestinal pain malignant and non-malignant pelvic pain in males and females rectal pain and chest pain.

• Discusses key demographic characteristics as well as clinical and diagnostic presentations of the most common and esoteric visceral pain syndromes that will enable clinicians to identify pain generators. 

• Provides a truly systematic approach to the treatment of chronic visceral pain, including the use of pharmacologic, non-interventional, interventional, and multidisciplinary therapies with evidence-based data. 

• Covers the indications, contraindications, and outcomes results of the newest interventional treatments that all clinicians should be aware of, including neuromodulation and intrathecal pump therapy. 

Edited by Daniel J. Pak, MD, Assistant Professor of Clinical Anesthesiology, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States ; Jason Yong, MD, MBA, Assistant Professor of Anesthesia, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States and Krishna Shah, MD, Assistant Professor of Anesthesiology, Baylor St. Luke’s Medical Center, Baylor College of Medicine, Houston, TX, United States